Apolipoprotein C-III Deficiency
|
0.610 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Apolipoprotein C-III Deficiency
|
0.610 |
Biomarker
|
disease |
CTD_human |
|
|
|
Hypercholesterolemia
|
0.460 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Hypercholesterolemia
|
0.460 |
Biomarker
|
disease |
HPO |
|
|
|
Hyperlipidemia
|
0.200 |
Biomarker
|
disease |
HPO |
|
|
|
Hypotriglyceridemia
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Decreased LDL cholesterol concentration
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
APOLIPOPROTEIN C-III, NONGLYCOSYLATED PHENOTYPE
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Increased HDL cholesterol concentration
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypertriglyceridemia
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice.
|
2167514 |
1990 |
Obesity, Visceral
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content.
|
21829161 |
2012 |
Hypercholesterolemia
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Hypercholesterolemia is associated with the apolipoprotein C-III (APOC3) genotype in children receiving HAART: an eight-year retrospective study.
|
22848358 |
2012 |
Hyperlipidemia
|
0.200 |
GeneticVariation
|
disease |
LHGDN |
Apolipoprotein C-III and E polymorphisms and cardiovascular syndrome, hyperlipidemia, and insulin resistance in renal transplantation.
|
12118856 |
2002 |
Coronary Arteriosclerosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
ApoC-III gene polymorphisms and risk of coronary artery disease.
|
12235176 |
2002 |
Coronary Artery Disease
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
ApoC-III gene polymorphisms and risk of coronary artery disease.
|
12235176 |
2002 |
Coronary Artery Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
ApoC-III gene polymorphisms and risk of coronary artery disease.
|
12235176 |
2002 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
ApoC-III gene polymorphisms and risk of coronary artery disease.
|
12235176 |
2002 |
Metabolic Syndrome X
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
ApoC-III levels were significantly increased in MS patients, and the probability of having MS was correlated with increasing quartiles of apoC-III levels.
|
14563827 |
2003 |
Cardiovascular Diseases
|
0.400 |
Biomarker
|
group |
BEFREE |
Apolipoprotein C-III (apo C-III) is a marker of cardiovascular disease risk associated with triglyceride (TG)-rich lipoproteins.
|
15576429 |
2005 |
Dyslipidemias
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Apolipoprotein C-III (apoC-III) gene variants, which vary by race/ethnicity, have been associated with a lipid profile that resembles PI-induced dyslipidemia.
|
16417409 |
2006 |
Coronary Arteriosclerosis
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
APOC3 polymorphisms were associated with lipid parameters and coronary artery disease in several populations but not all.
|
17367769 |
2007 |
Coronary Artery Disease
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
APOC3 polymorphisms were associated with lipid parameters and coronary artery disease in several populations but not all.
|
17367769 |
2007 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
APOC3 polymorphisms were associated with lipid parameters and coronary artery disease in several populations but not all.
|
17367769 |
2007 |
Dyslipidemias
|
0.100 |
GeneticVariation
|
group |
BEFREE |
APOC3 polymorphisms might be associated with both dyslipidemia and lipoatrophy in HAART-treated patients.
|
18240956 |
2008 |
Lipodystrophy
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
APOC3 polymorphisms might be associated with both dyslipidemia and lipoatrophy in HAART-treated patients.
|
18240956 |
2008 |